Hépatite et myolyse sous Simvastatine succédant à cinq ans de traitement par le Gemfibrozil

The occurrence of myolysis and hepatitis in a 60-year old man under Simvastatine following a five year therapy with Gemfibrozil precludes the association of these two drugs and demands a wash-out period before substituting an reductase inhibitor for Gemfibrozil and vice versa.